Mayo Clinic researchers are aiming to determine the safety of using an autologous mesenchymal stromal cell (MSC) coated fistula plug in people with rectovaginal fistulizing Crohn's disease.
Investigators are trying to compare standard of care lung protective ventilation settings with an automated ventilator setting, called Adaptive Support Ventilation (ASV), in patients with acute respiratory distress syndrome (ARDS). This study will compare measurements (i.e. tidal volumes, driving pressure, respiratory rate (RR), compliance, peak airway pressures, plateau pressures, PEEP) with each ventilator technique, and will measure esophageal pressures to compare transpulmonary and respiratory system mechanics.
The 40th World Dental Science and Oral Health Congress will be held in Singapore from August 21-22, 2019 with the theme “Innovative Ideas and Approaches in Dental Science and Oral Health Care”.
EEP 19, The first Transurethral Endoscopic Enucleation of the Prostate, an Endourology Symposium is scheduled to be held on September 9-10, 2019 at the Paracelsus Medical University, Salzburg/Austria.
The 19th WPA World Congress Of Psychiatry is being organized by the World Psychiatric Association which will be held on the 21-24 August 2019 in Lisbon, Portugal. It aims to examine and discuss all these crucial issues in psychiatry and mental health, listening to numerous keynote lectures that convoy our present scientific and technological revolution.
This study examines the aphasia treatment response among Veterans and non-Veterans living with aphasia. It seeks to identify cognitive and neural factors which are predictive of positive response to treatment targeting naming impairments in aphasia. It also examines the dose-response relationship for naming treatment. More broadly, it seeks to determine who aphasia therapy works best for, and how much aphasia therapy is sufficient to achieve a positive treatment response.
This phase I/II trial studies the side effects and best dose of plinabulin when given together with nivolumab and to see how well they work in treating patients with stage IIIB-IV non-small cell lung cancer that has come back or spread to other places in the body. Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as plinabulin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving nivolumab and plinabulin together may work better at treating patients with non-small cell lung cancer.
This research study is looking at an antibiotic medicine, Ceftaroline Fosamil (Ceftaroline), which fights infections like the one you have. Ceftaroline is effective against S.aureus germs including those that are called methicillin-resistant S. aureus or Methicillin-Resistant Staphylococcus aureus (MRSA). The investigators are also studying what the body does to the study drug, Ceftaroline, and if the doses the investigators use the result in blood levels that the investigators think are going to be effective against bone infections in children.
The purpose of this study is to study the effects of topical Vitamin D cream (Calcipotriene, also known as Dovonex) on acne. This study will be a randomized, double-blinded, parallel-group comparison of calcipotriene vs. placebo cream. The information gained from this study may lead to new treatments for acne. In this study, Calcipotriene will be compared with a placebo, a cream that looks like Calcipotriene but contains no active ingredients.
Keila Lopez from Division of Pediatric Cardiology Texas Children's Hospital presented a talk on understanding the inequities during the transition period for chronic disease in adolescents, understanding the evolution of healthcare technology and adolescent use, describing the role of technology in adolescent brain and understanding technologies that may improve health inequities for chronic disease adolescents.